When regulatory T cells go bad
LA JOLLA, CA—Scientists can finally hunt down a harmful kind of human T cell, thanks to new research led by
A new look inside Ebola’s ‘viral factories’
LJI researchers reveal a hidden side of how Ebola virus replicates inside host cells
Gregory Seumois is poised to answer big questions in asthma and respiratory allergies research
"Tackling significant health challenges in science and research is best approached as a cohesive but multi-disciplinary group."
A scientist and writer supports life-changing programs around the world
LJI's Sharon Schendel works to improve global health through the Rotary Club of Del Mar
LJI and Kyowa Kirin launch immunology fellowship program
New Michael Croft Fellowship in Immunology Fund to provide vital support for early career scientists
Asymptomatic infections may underlie recent rise in whooping cough
Surprising insights on pertussis vaccines pave the way for next-gen protection
New algorithm may fuel vaccine development
Computational biologists harness machine learning to make sense of immune system data
LJI advocates for more research into immune system differences between men and women
Institute President and CEO Erica Ollmann Saphire, Ph.D., joins national leaders in highlighting the importance of studying sex-based immune system differences
Powerhouses
LJI's Immunometabolism Core gives researchers a closer look at how cells gather energy to fight disease
Benjamin J. Schmiedel wants a closer look at the role of genetics in immune cell function
LJI’s new Research Assistant Professor hopes genetic research will help patients with immune-mediated diseases such as inflammatory bowel disease, asthma, Alzheimer’s, and COVID-19
Blocking immune system ‘messenger’ may treat severe asthma
LA JOLLA, CA—Asthma is more dangerous than many people realize. An estimated 10 Americans die everyday from asthma, and the
Family resemblance: How T cells could fight many coronaviruses at once
LJI researchers work to head off future pandemics by uncovering key similarities between SARS-CoV-2 and common cold coronaviruses